CONMED Corporation (NYSE:CNMD) today announced its participation in the Jefferies Global Healthcare Conference, which is being held November 16-19, 2026 at the Waldorf Hilton and ME Hotel in London, UK.
Management
CONMED Corporation (NYSE:CNMD) today reported financial results for the third quarter ended September 30, 2026 and updated its financial guidance for the full year ending 2026.
Third Quarter 2026
CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the third quarter 2026 after the market close on Wednesday, October 28, 2026. The Company’s management will host a conference
CONMED Corporation (NYSE:CNMD) today announced its participation in the Wells Fargo 21st Annual Healthcare Conference, which is being held September 8-10, 2026 at the Encore Boston Harbor in Everett, MA.
Management
CONMED Corporation (NYSE:CNMD) today reported financial results for the second quarter ended June 30, 2026 and updated its financial guidance for the full year ending 2026.
Second Quarter 2026 Highlights(1)
Sales
CONMED Corporation (NYSE:CNMD) today announced that its AirSeal® Robotic Solution is now indicated for use with Intuitive’s 8 mm hex cannulas used as part of the Intuitive da Vinci 5 platform ("dV5"). Alongside
Professor Nikhil Vasdev to Present Results of a Recently Published Clinical Trial Featuring AirSeal® technology
CONMED Corporation (NYSE:CNMD) today announced its participation in the Society of Robotic Surgery (SRS)
CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the second quarter 2026 after the market close on Wednesday, July 29, 2026. The Company’s management will host a conference call
CONMED Corporation (NYSE:CNMD) today announced the appointment of John E. Gallagher as Chief Financial Officer ("CFO"), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an
CONMED Corporation (NYSE:CNMD) today announced the appointment of Celine Martin and Jeff Mirviss to its Board of Directors ("Board"), effective July 1, 2026. Ms. Martin will serve as a member of the Audit Committee and
CONMED Corporation (NYSE:CNMD) today announced financial results for the first quarter ended March 31, 2026.
First Quarter 2026 Highlights
Sales of $317.0 million decreased 1.3% year-over-year as reported and 2.9%
CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the first quarter 2026 after the market close on Wednesday, April 29, 2026. The Company's management will host a conference call
CONMED Corporation (NYSE:CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2025.
Fourth Quarter 2025 Highlights
Sales of $373.2 million increased 7.9% year-over-year as
Todd Garner to step down as CONMED's CFO, effective March 15, 2026, and remain In an Advisory Role Through November 2, 2026
Company Initiates Comprehensive Search for Next Chief Financial Officer
CONMED Reaffirms
CONMED Corporation (NYSE:CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 44th Annual J.P.
